Evaluation of antimotion sickness drugs: a new effective remedy revealed.
D000293:Adolescent; D000328:Adult; D006631:Amine Oxidase (Copper-Containing) / Q000037:antagonists & inhibitors; D001621:Betahistine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology; D004809:Ephedrine / Q000494:pharmacology; D005021:Ethylamines / Q000494:pharmacology; D006801:Humans; D008297:Male; D009041:Motion Sickness / Q000188:drug therapy*; D010879:Piperazines / Q000494:pharmacology; D011398:Promethazine / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D012601:Scopolamine / Q000494:pharmacology
D005021:Ethylamines; D010879:Piperazines; D011725:Pyridines; D012601:Scopolamine; D006631:Amine Oxidase (Copper-Containing); D011398:Promethazine; D004809:Ephedrine; D003913:Dextroamphetamine; D001621:Betahistine